RespiQ provides a handheld sensor that can detect and quantify any volatile molecule in real time across medical, lifestyle, and industrial settings. By combining photonic detection hardware with AI-driven analytics, it delivers high‑sensitivity breath biomarkers for chronic respiratory disease monitoring and continuous molecular monitoring for leak detection, pollutant tracking, and process control.
Funding
$120K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting volatile biomarkers in breath or industrial environments rely on bulky laboratory equipment, invasive procedures, or delayed analysis, limiting timely disease management and process control.
Solution
RespiQ offers a compact, handheld sensor platform that can detect and quantify any volatile molecule in real time across diverse settings, from home breath testing to industrial process monitoring. The device combines integrated electronics, photonics, and AI-driven algorithms to deliver high‑sensitivity, high‑specificity measurements without the need for specialized operators. For chronic respiratory conditions such as COPD, the sensor captures disease‑related biomarkers in a single breath, generating a personalized breathprint that predicts exacerbations and enables remote clinician review. In industrial applications, the same technology provides continuous leak detection, pollutant monitoring, and process parameter tracking, giving operators actionable insights to improve safety and efficiency.
Target Audience
Primary customers include healthcare providers and patients managing chronic respiratory diseases, as well as industrial operators in logistics, chemical manufacturing, and bioprocessing seeking continuous molecular monitoring.
Features
- Handheld, portable sensor capable of detecting any volatile molecule in any gaseous environment
- Integrated photonic and electronic detection hardware delivering high sensitivity and specificity
- Proprietary AI algorithms that translate raw sensor data into actionable breathprints or process metrics
- Real‑time data transmission to cloud platforms for remote monitoring and analytics
- Cloud‑based dashboard for clinicians and operators to view trends, alerts, and predictive insights
- Compatibility with both home use (patient self‑monitoring) and point‑of‑care or industrial deployment